Insider Transactions Reported by 14 Insiders of TENAX THERAPEUTICS, INC.

Symbol
TENX on Nasdaq
Location
Chapel Hill, NC

Insiders trading volume in the past year

TENAX THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Thomas Giordano CEO, Director $4,073,445 +$20,000 +0.49% 09 Jan 2026
Stuart Rich Chief Medical Officer, Director $2,363,886 +$96,414 +4.3% 09 Jan 2026
Michael H. Davidson Director $948,429 09 Jan 2026
PROEHL GERALD T Director $719,829 09 Jan 2026
Declan Doogan Director $290,466 09 Jan 2026
June Sherie Almenoff Director $287,937 +$14,945 +5.5% 09 Jan 2026
Robyn Hunter Director $270,000 09 Jan 2026
Thomas Mcgauley Interim CFO $72,000 +$58,164 +420% 30 Jan 2026
Lawrence R. Hoffman Interim CFO 11 Jan 2024
Anthony A. DiTonno CEO, Director 06 Jul 2021
Eliot M. Lurier Interim CFO 29 Oct 2021
James P. Mitchum Director 10 Jun 2021
ARMISTICE CAPITAL, LLC Director 18 May 2022
Dellora Investments LP no longer 10% owner 05 Mar 2025

Recent Insider Transactions by Companies or Individuals for TENAX THERAPEUTICS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Thomas Mcgauley TENX Stock Option (right to buy) Options Exercise 50,000 50,000 30 Jan 2026 Direct
Michael H. Davidson TENX Stock Option (right to buy) Award 30,000 30,000 09 Jan 2026 Direct
Christopher Thomas Giordano TENX Stock Option (right to buy) Award 450,000 450,000 09 Jan 2026 Direct
Stuart Rich TENX Stock Option (right to buy) Award 250,000 250,000 09 Jan 2026 Direct
Proehl Gerald T TENX Stock Option (right to buy) Award 11.1% 3,000 30,000 09 Jan 2026 Direct
June Sherie Almenoff TENX Stock Option (right to buy) Award 30,000 30,000 09 Jan 2026 Direct
Declan Doogan TENX Stock Option (right to buy) Award 30,000 30,000 09 Jan 2026 Direct
Robyn Hunter TENX Stock Option (right to buy) Award 30,000 30,000 09 Jan 2026 Direct
Stuart Rich TENX Common Stock Purchase 90.4% $25,542 $10.22 2,500 5,266 09 Dec 2025 Direct
Stuart Rich TENX Common Stock Purchase 100% $25,250 $10.10 2,500 5,000 08 Dec 2025 By Stuart Rich Revocable Trust DTD 11/18/1996
Stuart Rich TENX Common Stock Purchase $22,998 $9.20 2,500 2,500 04 Dec 2025 By Stuart Rich Revocable Trust DTD 11/18/1996
Stuart Rich TENX Common Stock Purchase 118.5% $13,618 $9.08 1,500 2,766 03 Dec 2025 Direct
Stuart Rich TENX Common Stock Purchase 375.9% $9,006 $9.01 1,000 1,266 02 Dec 2025 Direct
Christopher Thomas Giordano TENX Common Stock Purchase 26% $4,083 $7.59 538 2,605 20 Nov 2025 Direct
Christopher Thomas Giordano TENX Common Stock Purchase 28.2% $3,417 $7.51 455 2,067 19 Nov 2025 Direct
Christopher Thomas Giordano TENX Common Stock Purchase $12,500 $7.75 1,612 1,612 18 Nov 2025 Direct
June Sherie Almenoff TENX Common Stock Purchase 2043% $14,280 $7.52 1,900 1,993 18 Nov 2025 By Meadowlark Management, LLC
June Sherie Almenoff TENX Common Stock Purchase $665 $7.15 93 93 17 Nov 2025 By Meadowlark Management, LLC
Thomas Mcgauley TENX Common Stock Purchase $36,140 $7.23 5,000 5,000 17 Nov 2025 By Spouse
Thomas Mcgauley TENX Common Stock Purchase $7,350 $7.35 1,000 1,000 17 Nov 2025 By Child
Thomas Mcgauley TENX Common Stock Purchase $14,674 $7.34 2,000 2,000 17 Nov 2025 Direct
June Sherie Almenoff TENX Stock Option (right to buy) Award 80,000 80,000 01 Jul 2025 Direct
Michael H. Davidson TENX Stock Option (right to buy) Award 80,000 80,000 01 Jul 2025 Direct
Declan Doogan TENX Stock Option (right to buy) Award 80,000 80,000 01 Jul 2025 Direct
Proehl Gerald T TENX Stock Option (right to buy) Award 80,000 80,000 01 Jul 2025 Direct
Robyn Hunter TENX Stock Option (right to buy) Award 80,000 80,000 01 Jul 2025 Direct
Stuart Rich TENX Stock Option (right to buy) Award 625,000 625,000 16 May 2025 Direct
Christopher Thomas Giordano TENX Stock Option (right to buy) Award 1,400,000 1,400,000 16 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.